LIST OF PARTICIPANTS AT THE 11th ANNUAL GENERAL MEETING & CONFERENCE OF THE DEVELOPING COUNTRIES VACCINE MANUFACTURERS NETWORK ON 13 – 16 SEPTEMBER 2010, AT NOVOTEL CONVENTION CENTER, HYDERABAD, ANDHRA PRADESH, INDIA.

MEMBERS OF THE DCVMN:

Organization S.No. Name of the Member Organization No. 1 1 Dr. Ella, Krishna, M Bharat Biotech International Limited, Chairman & Managing Director Genome Valley, Shameerpet (M), Hyderabad, Andhra Pradesh, India. 500 078

2 Dr. Krishna Mohan, V Bharat Biotech International Limited President Genome Valley, Shameerpet (M), Hyderabad, Andhra Pradesh, India. 500 078

3 Mr. Prasad, Sai D. Bharat Biotech International Limited, Vice President Genome Valley, Shameerpet (M), Hyderabad, Andhra Pradesh, India. 500 078

4 Dr. Harshavardhan, G.V.J.A Bharat Biotech International Limited, Director - Rotavirus Vaccine Genome Valley, Shameerpet (M), Development Project Hyderabad, Andhra Pradesh, India. 500 078

5 Dr. Srinivas, V.K Bharat Biotech International Limited, Vice President Genome Valley, Shameerpet (M), Hyderabad, Andhra Pradesh, India. 500 078

6 Dr. Kamaraj, G Bharat Biotech International Limited, General Manager: Production Genome Valley, Shameerpet (M), Hyderabad, Andhra Pradesh, India. 500 078

7 Mr. Gopinathan, K Bharat Biotech International Limited, Assistant General Genome Valley, Shameerpet (M), Manager, Quality Control. Hyderabad, Andhra Pradesh, India. 500 078

8 Mr. Venkatesan, R Bharat Biotech International Limited, Assistant General Manager, Genome Valley, Shameerpet (M), Production. Hyderabad, Andhra Pradesh, India. 500 078

2 9 Ms. Datla, Mahima Biological E. Limited, Sr. Vice President 18/1&3, Azamabad, Hyderabad, India. 500 020

10 Mr. Mantena, Narender Dev Biological E. Limited, Sr. Vice President – SBD 18/1&3, Azamabad, Hyderabad, India. 500 020

11 Mr. Rayasam (Ray) Prasad Biological E. Limited, Chief Operating Officer 18/1&3, Azamabad, Gloabal Biologics Hyderabad, India - 500 020

12 Mr. Mahesh Kulkarni Biological E. Limited, Vice President , Quality Assurance 18/1&3, Azamabad, Hyderabad, India - 500 020

13 Dr. Mahesh Balghat Biological E. Limited, Vice President, Quality Control. 18/1&3, Azamabad, Hyderabad, India - 500 020

14 Ms. Sofi Joseph Biological E. Limited, Assistant General Manager, 18/1&3, Azamabad, Regulatory Affairs Hyderabad, India - 500 020

15 Mr. Giridhar Rao Biological E. Limited, Deputy Manager, Quality Assurance. 18/1&3, Azamabad, Hyderabad, India - 500 020

16 Dr. L. R. Sood Biological E. Limited, Sr. Vice President. 18/1&3, Azamabad, Hyderabad, India - 500 020

17 Mr. Benjamin Stephen Biological E. Limited, DGM - Quality Control Plot No.1, Phase II, SP Biotech Park, Genome Valley, Kolthur Village, Shameerpet Mandal, R.R. Dist. Andhra Pradesh. India - 500 078

3 18 Dr. Homma, Akira BioManguinhos / Fiocruz, Chairman of Policy and Strategy Council Rio de Janeiro Avenida Brasil, 4635 Manguinhos, Rio de Janeiro, Brazil. 21040-360

19 Dr. Leal, Maria da Luz Fernandes BioManguinhos / Fiocruz, Deputy Director of Quality Rio de Janeiro Avenida Brasil, 4635 Manguinhos, Rio de Janeiro, Brazil. 21040-360 20 Mr. Couto, Artur BioManguinhos / Fiocruz, Roberto Director Rio de Janeiro Avenida Brasil, 4635 Manguinhos, Rio de Janeiro, Brazil. 21040-360

21 Dr. Freire, Marcos da Silva BioManguinhos / Fiocruz, Deputy Director Technological Rio de Janeiro Avenida Brasil, Development 4635 Manguinhos, Rio de Janeiro, Brazil. 21040-360

4 22 Dr. Suhardono, Mahendra PT. Bio Farma (Persero), Production Director JI. Pasteur 28, Bandung, Indonesia. 40161.

23 Mr. Mas Rahman Roestan PT. Bio Farma (Persero), Corporate Secretary JI. Pasteur 28, Bandung, Indonesia. 40161.

5 24 Mr. Vonghangool, Vitoon Bionet-Asia Co.Ltd., Managing Director 889 Thai cc Tower, 10th Floor, Room 103, South Sathorn, Bangkok 10120, Thailand.

25 Dr. Pham, Hong Thai Bionet-Asia Co.Ltd., Director 889 Thai cc Tower, 10th Floor, Room 103, South Sathorn, Bangkok 10120, Thailand.

26 Mr. Biswas, Arun International Bionet-Asia Co.Ltd., Business Director My Home Rainbow, Flat # 607 (indigo), 8-1-329/1, Tolichowki, Hyderabad 500 008, Andhra Pradesh. India.

6 27 Dr. Makhoana, Morena The Biovac Institute, Chief Executive Officer 15 Alexandra Road, Private Bag X3, Pinelands 7430, Cape Town 7405, South Africa.

28 Mr. Duyse, Richard van The Biovac Institute, Chief Operating Officer 15 Alexandra Road, Private Bag X3, Pinelands 7430, Cape Town 7405, South Africa.

29 Mr. Kahanovitz, Selwyn The LITHA Healthcare Group Limited, Group Chief Executive Officer 1, Manchester Road, Wadeville, 1428, P O Box 14374, Wadeville 1422, South Africa. 7 30 Dr. Leon, Samuel Ponce de Laboratorios de Biologicos y General Director Reactivos de Mexico (BIRMEX), Amores 1240, Col. Del Valle, CP 03100, Mexico City, Mexico – 03100

31 Dr. Catalan, Francisco Padilla Laboratorios de Biologicos y Commercial Deputy General Director Reactivos de Mexico (BIRMEX), Amores 1240, Col. Del Valle, CP 03100, Mexico City, Mexico – 03100

32 Ms. Lopez, Angelica Laboratorios de Biologicos y QC/QA Deputy General Director Reactivos de Mexico (BIRMEX), Mariano Escobedo No.20, Col. Popotla, Mexico city, Mexico – 11400

8 33 Dr. P.S.Maruthi Sai Cadila Pharmaceuticals Limited, Vice President 1389, Trasad Road, Dholka 387 810 R & D Biotech Dist.: Ahmedabad, Gujarat, India.

34 Mr. M. Jeevan Kumar Cadila Pharmaceuticals Limited Vice President: Commercial 1389, Trasad Road, Dholka 387 810 CPL Biologics Dist : Ahmedabad, Gujarat, India.

9 35 Dr. Hamdallah Zedan Egyptian Company for Production of Chairman & CEO Vaccines, Sera and Drugs, VACSERA, Giza, Egypt.

10 36 Mr. Sit Thirapakpoomanunt Director Government Pharmaceutical Organization, (Actiing), Biological Product Rama VI Rd. Ratchathewi, Department Bangkok 10400, Thailand.

37 Mr. Pattharachai Lakornrach Chief, Government Pharmaceutical Organization, JE Vaccine Section Rama VI Rd. Ratchathewi, Bangkok 10400, Thailand.

38 Dr. Somchaiya Government Pharmaceutical Organization, Surichan Researcher Rama VI Rd. Ratchathewi, Bangkok 10400, Thailand.

11 39 Dr. Leite, Luciana C.C Instituto Fundacao Butantan, Director of Center of Biotechnology Av.Vital Brasil 1500 0553-900, Sao Paulo, SP, Brazil. 12 40 Dr. G.S. Reddy Indian Immunologicals limited, Chief General Manager Road No. 44, Jubilee Hills, Hyderabad, Andhra Pradesh 500 033, India.

41 Mr. B. Venugopal Rao Indian Immunologicals limited, Manager - Quality Assurance Road No. 44, Jubilee Hills, Hyderabad, Andhra Pradesh 500 033, India.

13 42 Ms. Kim, Sung Yeon S. LG Life Sciences Limited, th Product Manager 16 Floor, East Tower, LG Twin Towers, 20 Yoido-dong, Youngdungpo-gu, Seoul, R. of Korea, 150-791.

43 Dr. Choi, Doeg-Young LG Life Sciences Limited, Head/Vaccine Development SEOUL, LG Twin Towers, 20 Yoido-dong, Youngdungpo-gu, Seoul, R. of Korea, 150-721.

44 Dr. Deepali Mittal LG Life Sciences India Pvt Ltd, Assistant General Manager LG House, Plot No.11, Sector 44, Clinical Research Gurgaon 122001, India.

45 Dr. Mita Nandy LG Life Sciences India Pvt Ltd, Vice President LG House, Plot No.11, Sector 44, Medical Services & Clinical Research Gurgaon 122001, India.

14 46 Mr. Jain, Sumit Panacea Biotec Ltd, Director, Operations B-1, Extn/A-27, Mohan Co-op Industrial Estate, Mathura Road, New Delhi-110044, India.

47 Mr. Suri, Rajinder K Panacea Biotec Ltd, Chief Executive, Biologicals B-1, Extn/A-27, Mohan Co-op Industrial Estate, Mathura Road, New Delhi-110044, India.

48 Mr. Ahmed, Syed Panacea Biotec Ltd, Head, International Vaccine Business B-1, Extn/A-27, Mohan Co-op Industrial Estate, Mathura Road, New Delhi-110044, India. 49 Ms. Khanna, Navita Panacea Biotec Ltd, GM, Institutional Business Vaccine B-1, Extn/A-27, Mohan Co-op Industrial Estate, Mathura Road, New Delhi-110044, India.

50 Ms. Khalid, Sonia Panacea Biotec Ltd, Assistant General Manager B-1, Extn/A-27, Mohan Co-op Industrial Estate, Mathura Road, New Delhi-110044, India.

15 51 Dr. Cyrus S. Poonawalla Serum Institute of India Ltd, Chairman & Managing Director 212/2 Hadapsar, Off Soli Poonawalla Road, Pune 411 028, India

52 Mr. Adar C. Poonawalla Serum Institute of India Ltd, Executive Director - Operations 212/2 Hadapsar, Off Soli Poonawalla Road, Pune 411 028, India.

53 Dr. Jadhav, Suresh S. Serum Institute of India Ltd, Executive Director 212/2 Hadapsar, Off Soli Poonawalla Road, Pune 411 028, India.

16 54 Mr. Xu, Wenqing Sinopharm CNBG: Shanghai Institute of Director of Vaccine Division II Biological Products, No.1262 Yan’an West Road Shanghai, China 20052.

17 55 Mr. Guo, Lijun Sinopharm CNBG: Changchun Institute of Vice Director Biological Products, No. 137, Xi’an Road, Changchun, China – 610023.

56 Mr. Xie, Yinglin CNBG: Changchun Institute of Biological Manager of import & export Dept. Products, No. 137, Xi’an Road, Changchun, China – 610023.

18 57 Ms. Zhou, Wei Sinopharm CNBG: Wuhan Institute of Biological Products, No. 9, Linjiang Street, Wuhan, China- 430060. 19 58 Ms. Wang, Hui Sinopharm, CNBG: Beijing Tiantan Manager of QA & QC Biological Products Limited, No. 4 San-jian-fang-nan-li, Chaoyang District, Beijing, China – 100024

20 59 Dr. Do Tuan Dat VABIOTECH, The Company for Vaccine Deputy Chief of R & D and Biological Production No.1 1, Yersin Street, 10000 Hanoi, Vietnam.

60 Mr. Trinh Tuan Viet VABIOTECH, The Company for Vaccine Researcher R & D and Biological Production No.1 1, Yersin Street, 10000 Hanoi, Vietnam

21 61 Dr. (Ms.) Ting, Wu Xiamen Innovax Biotech Medical Affairs, Manager Bio Xinyuan Road, Haichang, Xiamen, Fujian, China – 361022

62 Mr. Yongzhong, Gao Xiamen Innovax Biotech General Manager Bio Xinyuan Road, Haichang, Xiamen, Fujian, China – 361022

22 63 Dr. Kui, Chen Xue Zhejiang Tianyuan Bio-Pharmaceuticals Deputy General Manager Co., Ltd, 56, Tianhe Road, Linping, Hangzhou City, Zhejiang Province, P.R. China – 311100

64 Mr. Liao, Sam Zhejiang Tianyuan Bio-Pharmaceuticals Chief Operations Officer Co., Ltd, 56, Tianhe Road, Linping, Hangzhou City, Zhejiang Province, P.R. China – 311100. RESOURCE MEMBERS :

Organization S.No Name of the Member Organization No. .

23 65 Mr. Cunningham, Gerard Bill and Melinda Gates Foundation, Senior Program Officer 1432, Elliot Avenue. W Seattle, WA-98199.

66 Ms. Chandrasekaran, Padma Bill and Melinda Gates Foundation, 1432, Elliot Avenue. W Seattle, WA-98199.

67 Mr. Ramesh Rao (Raja) Bill and Melinda Gates Foundation, Senior Program Officer P.O. Box 23350, Seattle, WA-98102, USA.

68 Dr. Holtzman, Douglas A. Bill and Melinda Gates Foundation Senior Program Officer : Infectious 1432, Elliot Avenue. Diseases W Seattle, WA 98119, USA.

24 69 Dr. Jiang, Baoming Centers for Disease Control & Team Leader, Gastroenteritis & Prevention, Respiratory Virus Lab Branch, 1600 Clifton Road, Mail Stop G - 04, DVD/NCIRD, Atlanta, GA 30333 USA.

25 70 Dr. Wilson, Paul Columbia University Associate Professor 780, Riverside Drive New York, NY, USA 10032

26 71 Dr. Yusibov, Vidadi Fraunhofer USA, Executive Director Center for Molecular Biotechnology, 9, Innovation Way, Suite 200. Newark, Delaware 19799, USA.

27 72 Mr. Pearman Jonathan GAVI Alliance Secretariat Head of Accelerated Vaccine Introduction. CH-1211, Geneva 10, Switzerland. 28 73 Prof. Dr. Boog, Claire Netherlands Vaccin Instituut, Scientific Director Antonie van Leeuwenhoeklaan 9-11, P O Box 457, 3720 AL Bilthoven, Netherlands.

74 Dr. Belt, Peter Netherlands Vaccin Instituut, Manager Antonie van Leeuwenhoeklaan 9-11, Marketing and Business Development P O Box 457, 3720 AL Bilthoven, Netherlands.

75 Ir. Hamidi, Ahd Netherlands Vaccin Instituut, Scientific Director Antonie van Leeuwenhoeklaan 9-11, P O Box 457, 3720 AL Bilthoven, Netherlands.

76 Mr. Heuvel, Nico van den Netherlands Vaccin Instituut, Manager, Technology Transfer. Antonie van Leeuwenhoeklaan 9-11, P O Box 457, 3720 AL Bilthoven, Netherlands.

29 77 Dr. Rohrbaugh, Mark NIH/Dept. HHS Director, Office of Technology Transfer Office of Technology Transfer 6011 Executive Blvd., Suite 325 Rockville, MD 20852 – 3804

30 78 Dr. Boslego, John W. PATH Director, Vaccine Development 1800 K Street, NW Global Program Suite 800, Washington, DC, USA – 20004

79 Ms. Stanfill, Allison PATH Program Assistant 1800 K Street, NW Suite 800, Washington, DC, USA – 20004

80 Dr. Alderson, Mark R. PATH Director, Pneumococcal Vaccine Project P.O.Box 900922, Seattle, WA, USA. 98109

81 Dr. Yaich, Mansour PATH Vaccine Development Director Batiment Avant Centre, 13 chemin duLevant, 01210 Ferney- Voltaire, France.

82 Dr. Zehrung, Darin PATH Portfolio Leader, Vaccine Street: 2201, Westlake Avenue, Delivery Technologies Suite 200-Seatle, WA 98121. 83 Mr. Malvolti, Stefano PATH (Program for Appropriate Director, Strategic Vaccine Supply, Technology in Health), Accelerated Vaccine Introduction Batiment Avant Centre, 13 chemin duLevant, 01210 Ferney-Voltaire, France.

84 Dr. Dexiang, Chen PATH Senior Technical Officer Street: 2201, Westlake Avenue, Suite 200-Seatle, WA 98121.

85 Dr. Robertson, George PATH Senior Technical Advisor - Vaccine 1800 K Street, NW Development Global Program Suite 800, Washington, DC, USA – 20006

86 Mr. Preaud, Jean –Marie PATH Europe H. Senior Technical Officer 13, Chemin du Levant, Bat Avant-Centre, Ferney Voltaire, France 01210.

87 Dr. Thiry, Georges PATH – Europe Programme Officer 13, Chemin du Levant, Bat Avant-Centre, Ferney Voltaire, France 01210.

88 Dr. Walia, Kamini PATH-India Director, Research & Development A-9, Qutab Institutional Area, New Delhi, India – 110067.

31 89 Dr. Roumiantzeff, Micha Tuberculosis Vaccine Initiative(TBVI), Eolelhertweg 15, Lelystad, 8219 PH, The Netherlands.

32 90 Ms. Mckinney, Susan US Agency for International Senior Technical Advisor for Immunization. Development, Maternal and Child Health Division, Bureau for Global Health, GH, HIDN/ID, Rm. 3.7-015, Ronald Reagan Building, 1300 Pennsylvania Ave. N.W., Washington D.C.20523. USA. 33 91 Mr. Matthews, Robert UNICEF PLADS Contracts Manager Freihaven 2100 Copenhagen 0 Denmark 2100

34 92 Dr. Dellepiane, Nora de Rey Tolve World Health Organization, Scientist, Group Leader, QSS/IVB 20 Avenue Appia, CH- 1211, Geneva 27, Switzerland.

93 Mr. Kaddar, Miloud Health World Health Organization, Economist 20 Avenue Appia, CH- 1211, Geneva 27, Switzerland.

94 Dr. Lahouari, Belgharbi Scientist World Health Organization, 20 Avenue Appia, CH- 1211, Geneva 27, Switzerland.

95 Dr. Cherian, Thomas World Health Organization, Coordinator 20 Avenue Appia, CH- 1211, Geneva 27, Switzerland.

96 Dr. Knezevic, Ivana Scientist World Health Organization, QSS Team 20 Avenue Appia, CH - 1211, Geneva 27, Switzerland.

97 Dr. Kieny, Marie-Paul World Health Organization, Director: IVR 20 Avenue Appia, CH - 1211, Geneva 27, Switzerland.

98 Mr. Zaffran, Michel J. World Health Organization, Director, Project Optimize 20 Avenue Appia, CH - 1211, Geneva 27, Switzerland.

99 Dr. Claudia Alfonso World Health Organization, 20 Avenue Appia, CH - 1211, Geneva 27, Switzerland.

100 Mr .Guichard, Stephane Claude World Health Organization, World Health House, Indra Prastha Estate, New Delhi – 110 002, India. OTHER PARTICIPANTS:

Organization S.No. Name of the Member Organization No. 35 101 Dr. Seals, Jonathan US Department of Health and Human Chief – Technology Advisory Team Services, HHS/ASPR/BARDA 330 Independence Ave SW RM G640 Washington, DC 20201 USA.

102 Dr. Iyer, Narayan US Department of Health and Human HHS/ASPR/BARDA Services, Switzer Building, Room 2302 330C Street, SW Washington, DC 20201 USA.

103 Ms. Hartman, Christina US Department of Health and Human HHS/ASPR/OPP Services, 330 C Street, SW Switzer Building, Room 5121 Washington, DC 20024 USA.

104 Dr. Miller, Daniel US Department of Health and Human Director, International Influenza Services, Unit HHS/OGHA, Switzer Building, Room 2302 330C Street, SW Washington, DC 20201 USA.

105 Ms. Ramirez, Sarah US Department of Health and Human HHS/OGHA Services, Switzer Bldg., Room 2301 330C Street, SW Washington, DC 20201 USA.

36 106 Mr. Greenberger, Noel McKinsey & Company 21 South Clark Street Suite 2900 Chicago, Illinois 60603-2900 USA.

107 Mr. Newkirk, Brian McKinsey & Company 21 South Clark Street Suite 2900 Chicago, Illinois 60603-2900 USA. 37 108 Dr. Monfardini, Erica PricewaterhouseCoopers S.à r.l. Expert, Life Sciences and Pharma 400, route d’Esch, Industry B.P. 1443 L-1014, Luxembourg.

38 109 Dr. Lal, Altaf Hilleman Laboratories, th Chief Executive Officer 7 Floor, Vatika Tower – B, Sector 54, Golf Course Road, Gurgaon 122 001, India.

110 Dr. Akshay Goel Hilleman Laboratories, th 7 Floor, Vatika Tower – B, Sector 54, Golf Course Road, Gurgaon 122 001, India.

39 111 Dr. Shirshendu Mukerjee Clinton Health Access Initiative Strategic Advisor William J. Clinton Foundation, 55 West 125th Street, New York, NY 10027. 112 Mr. Neeraj Mohan Clinton Health Access Iniative Director, Strategic Partnerships- William J. Clinton Foundation, Asia 55 West 125th Street, New York, NY 10027. 113 Dr. Sebastian Ku Clinton Health Access Initiative William J. Clinton Foundation, 55 West 125th Street, New York, NY 10027. 40 114 Ms. Anju Gupta Kaudanya VHB Medi Sciences Ltd, th Managing Director T-351, Tower No.8, 5 Floor, Belapur Railway Station Complex, CBD Belapur, Navi Mumbai 400614 India.

115 Mr. Ashok Shetty VHB Medi Sciences Ltd, th Manager T-351, Tower No.8, 5 Floor, Belapur Railway Station Complex, CBD Belapur, Navi Mumbai 400614 India.